Learn more at LeadIQ.com

Insights

Gathering insights about InflaRx…

Similar companies to InflaRx

InflaRx Tech Stack

InflaRx uses 8 technology products and services including Google Font API, OWL Carousel, CentOS, and more. Explore InflaRx's tech stack below.

Google Font API
Font Scripts
OWL Carousel
Javascript Libraries
CentOS
Operating Systems
Java
Programming Languages
Piwik
System Analytics & Monitoring
Video.js
Video Players
OpenSSL
Web Server Extensions
Apache
Web Servers

Media & News

InflaRx GmbH launched Gohibic commercially in the U.S. on Jun 21st '23.
InflaRx launched Gohibic commercially in the U.S. on June 21, 2023, for critically ill COVID-19 patients.
Sep 26, 2024 | www.investing.com
InflaRx GmbH launched The InflaRx Commitment Program on Jan 1st '24.
In January 2024, InflaRx announced the launch of The InflaRx Commitment Program, pursuant to which the cost of GOHIBIC (vilobelimab) will be refunded for up to six (6) administered inpatient doses (the full treatment course) to institutions that meet the eligibility requirements, for patients who were administered GOHIBIC (vilobelimab) in line with its EUA and who died due to COVID-19 in the intensive care unit.
Sep 25, 2024 | www.globenewswire.com
InflaRx GmbH hires Jan as Vice President, Investor Relations & Capital Markets.
Jan joins InflaRx from Olink Proteomics where he was Vice President, Investor Relations & Capital Markets.
Feb 21, 2024 | finance.yahoo.com
InflaRx GmbH hired Jan Medina as Vice President and Head of Investor Relations on Feb 22nd '24.
InflaRx appoints Jan Medina as Head of Investor Relations.
Feb 21, 2024 | finance.yahoo.com
InflaRx GmbH hired Camilla Chong as Chief Medical Officer on Jul 1st '23.
InflaRx N.V. (Nasdaq: IFRX ), a clinical-stage biopharmaceutical company commercializing and developing anti-inflammatory therapeutics that target the complement system, today announced the appointment of Dr. Camilla Chong as Chief Medical Officer (CMO) of InflaRx, effective July 1, 2023.
Jun 28, 2023 | news.google.com
InflaRx GmbH launched Gohibic in the U.S on Jun 21st '23.
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, announced today the commercial launch of Gohibic (vilobelimab) in the U.S.
Jun 21, 2023 | www.globenewswire.com
Esco Aster Pte Ltd. partners with InflaRx GmbH.
HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced the manufacturing partnership with InflaRx for its COVID-19 treatment Gohibic (vilobelimab).
May 16, 2023 | www.wuxibiologics.com

InflaRx's Email Address Formats

InflaRx uses at least 1 format(s):

InflaRx Email Formats	Example	Percentage
First.Last@inflarx.de	John.Doe@inflarx.de	50%
First.Last@inflarx.de	John.Doe@inflarx.de	50%

Frequently Asked Questions

Where is InflaRx's headquarters located?

InflaRx's main headquarters is located at Jena, 07745 DE. The company has employees across 2 continents, including EuropeNorth America.

What is InflaRx's stock symbol?

InflaRx is a publicly traded company; the company's stock symbol is IFRX.

What is InflaRx's official website and social media links?

InflaRx's official website is inflarx.de and has social profiles on LinkedIn.

How much revenue does InflaRx generate?

As of September 2024, InflaRx's annual revenue reached $1.8M.

What is InflaRx's SIC code NAICS code?

InflaRx's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does InflaRx have currently?

As of September 2024, InflaRx has approximately 52 employees across 2 continents, including EuropeNorth America. Key team members include Chief Medical Officer: C. C.Head Of Business Development: I. O.Head Of Clinical Pharmacology And Pharmacokinetics: J. D.. Explore InflaRx's employee directory with LeadIQ.

What industry does InflaRx belong to?

InflaRx operates in the Biotechnology Research industry.

What technology does InflaRx use?

InflaRx's tech stack includes Google Font APIOWL CarouselCentOSJavaPiwikVideo.jsOpenSSLApache.

What is InflaRx's email format?

InflaRx's email format typically follows the pattern of . Find more InflaRx email formats with LeadIQ.

When was InflaRx founded?

InflaRx was founded in 2007.

InflaRx

InflaRx

Biotechnology ResearchJena, Germany51-200 Employees

InflaRx (Nasdaq: IFRX) is a biopharmaceutical company pioneering anti-inflammatory therapeutics by applying its proprietary anti-C5a and anti-C5aR technologies to discover, develop and commercialize highly potent and specific inhibitors of the complement activation factor C5a and its receptor C5aR. C5a is a powerful inflammatory mediator involved in the progression of a wide variety of inflammatory diseases. InflaRx’s lead product candidate, vilobelimab, is a novel, intravenously delivered, first-in-class, anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical studies in different indications. InflaRx is also developing INF904, an orally administered, small molecule inhibitor of the C5a receptor. InflaRx was founded in 2007, and the group has offices and subsidiaries in Jena and Munich, Germany, as well as Ann Arbor, MI, USA. For further information, please visit www.inflarx.com

Company Overview

Headquarters: Jena, 07745 DE
Website: inflarx.de
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: IFRX
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2007
Employees: 51-200

Media & News

Funding & Financials

$10M
InflaRx's revenue is in the range of $10M

Funding & Financials

$10M
InflaRx's revenue is in the range of $10M

Company Leadership

C. C.
Chief Medical Officer
✕
Access Insights for InflaRx and Millions of Other Companies
Sign up for full access to InflaRx information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for InflaRx and Millions of Other Companies
Sign up for full access to InflaRx information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
I. O.
Head Of Business Development
✕
Access Insights for InflaRx and Millions of Other Companies
Sign up for full access to InflaRx information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for InflaRx and Millions of Other Companies
Sign up for full access to InflaRx information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. D.
Head Of Clinical Pharmacology And Pharmacokinetics
✕
Access Insights for InflaRx and Millions of Other Companies
Sign up for full access to InflaRx information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for InflaRx and Millions of Other Companies
Sign up for full access to InflaRx information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. M.
Head Of Marketing
✕
Access Insights for InflaRx and Millions of Other Companies
Sign up for full access to InflaRx information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for InflaRx and Millions of Other Companies
Sign up for full access to InflaRx information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. V.
Head Of It
✕
Access Insights for InflaRx and Millions of Other Companies
Sign up for full access to InflaRx information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for InflaRx and Millions of Other Companies
Sign up for full access to InflaRx information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

J. D.
Head Of Clinical Pharmacology And Pharmacokinetics
✕
Access Insights for InflaRx and Millions of Other Companies
Sign up for full access to InflaRx information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for InflaRx and Millions of Other Companies
Sign up for full access to InflaRx information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. M.
Head Of Marketing
✕
Access Insights for InflaRx and Millions of Other Companies
Sign up for full access to InflaRx information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for InflaRx and Millions of Other Companies
Sign up for full access to InflaRx information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. P. N. D.
Director, Head Of Programme Management
✕
Access Insights for InflaRx and Millions of Other Companies
Sign up for full access to InflaRx information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for InflaRx and Millions of Other Companies
Sign up for full access to InflaRx information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. V.
Head Of It
✕
Access Insights for InflaRx and Millions of Other Companies
Sign up for full access to InflaRx information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for InflaRx and Millions of Other Companies
Sign up for full access to InflaRx information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
P. E.
Head Of Finance And Controlling / Vp Finance
✕
Access Insights for InflaRx and Millions of Other Companies
Sign up for full access to InflaRx information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for InflaRx and Millions of Other Companies
Sign up for full access to InflaRx information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.